Immunology
Immunology
批准号:
8198155
负责人:
R. PAUL JOHNSON
金额:
$36.47万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-15 至 2016-06-30
关键词:
AIDS VaccinesAntibodiesAntibody FormationBiological AssayBloodCellular ImmunityConsensusConsensus DevelopmentDataData AnalysesDatabasesEnsureEnzyme-Linked Immunosorbent AssayEvaluationFlow CytometryGenerationsGoalsGrantHIVHumoral ImmunitiesImmuneImmune responseImmunologyImmunophenotypingIndividualInfectionLaboratoriesLocationMeasurementPerformancePlayProtocols documentationReproducibilityResourcesSIVSerumSiteSpecimenStandardizationSubfamily lentivirinaeTestingVaccine ResearchVaccinesVaginaValidationVirusantibody-dependent cell cytotoxicitycomparativecytokineimprovedmucosal siteneutralizing antibodynonhuman primatepreventrectalresponsesimian human immunodeficiency virustransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall goals of the CAVR Immunology Core are to provide a centralized resource for analysis of SIV- and
SHIV-specific humoral immune responses in serum and mucosal specimens and to standardize the
performance of flow cytometric assays that will be carried out by individual laboratories. A comprehensive
range of well-standardized and quantitative assays of humoral immunity will be offerered, including a panel
of complementary assays for the determination of neutralizing antibody responses and a newly developed
assay that provides sensitive and reproducible determination of ADCC activity. To ensure consistent
generation of polychromatic flow cytometry data and assays of cell-mediated immunity, the Immunology
Core will coordinate the generation of consensus standard operating protocols (SOPs) for
immunophenotyping and cytokine flow cytometry (CFC) assays, and supervise the implementation and
validation of each SOP at each location. Specific Aims include: 1. To provide a centralized resource for the
analysis of SIV/SHlV-specific antibodies in sera using ELISA and SIV/SHIV neutralization assays; 2. To
provide a centralized resource for analysis of SIV and SHIV-specific antibody responses in vaginal and rectal
secretions; and 3. To ensure standardization of immunophenotyping and ICS assays conducted by different
sites through the development of consensus protocols, implementation of proficiency testing, and
comparative evaluation of flow cytometric data analysis. These activities will provide a comprehensive and
robust assessment of host immune responses elicited by these vaccine approaches and will help define
responses that are able to interrupt mucosal transmission of lentiviruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Annual Symposium on Nonhuman Primates
-
批准号:10676977
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2022
-
负责人:R. PAUL JOHNSON
-
依托单位:
Annual Symposium on Nonhuman Primates
-
批准号:10554035
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2022
-
负责人:R. PAUL JOHNSON
-
依托单位:
Exome screening and directed breeding of rhesus for human genetic disease models
-
批准号:9111085
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2015
-
负责人:R. PAUL JOHNSON
-
依托单位:
Exome screening and directed breeding of rhesus for human genetic disease models
-
批准号:8970022
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2015
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8357947
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8357913
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8357919
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection
-
批准号:8198148
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8357948
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8172859
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Construction of a Dual Function Primate Facility: ABSL3 and Transplant Medicine
-
批准号:7877509
-
项目类别:
-
资助金额:$1486.82万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8172823
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8085795
-
项目类别:
-
资助金额:$73.36万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8292099
-
项目类别:
-
资助金额:$75.6万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8172817
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Mechanisms of protective immunity induced by live attenuated SIV vaccines
-
批准号:8064463
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8467672
-
项目类别:
-
资助金额:$71.07万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
CD8+ T CELLS AND PROTECTION AGAINST VAGINAL CHALLENGE INDUCED BY SIVMAC239DELTA3
-
批准号:8172858
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:7988488
-
项目类别:
-
资助金额:$79.47万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8172860
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
海外基金